Trial Profile

A pivotal trial of PBFT-02 for the treatment of Frontotemporal dementia - GRN

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 16 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PBFT 02 (Primary)
Indications Frontotemporal dementia
Focus Registrational; Therapeutic Use

Most Recent Events

10 Jan 2025 According to a Passage Bio media release, company Seek regulatory feedback on registrational trial design in 1H 2026
16 Aug 2024 New trial record
08 Aug 2024 According to a Passage Bio media release, the company will seek regulatory feedback on the design of this pivotal trial in 2H 2025.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com